USPTO Examiner VU QUYNH NHU HOANG - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19269682LACTATION ASSEMBLYJuly 2025August 2025Allow100YesNo
19232175SYSTEMS, APPARATUS, AND METHODS FOR WARMING FLUID FOR INTRAVENOUS INFUSIONJune 2025March 2026Allow911NoNo
19021396AUTO-INJECTORJanuary 2025July 2025Allow610NoNo
19022461AUTO-INJECTORJanuary 2025August 2025Allow710NoNo
19021912AUTO-INJECTORJanuary 2025March 2025Allow200YesNo
19021557AUTO-INJECTORJanuary 2025July 2025Allow600YesNo
19020238AUTO-INJECTORJanuary 2025July 2025Allow620NoNo
18815035MILK BOWL AND WEARABLE BREAST PUMPAugust 2024July 2025Allow1120NoNo
18680212Auto-injectorMay 2024May 2025Allow1111NoNo
18680366Auto-injectorMay 2024May 2025Allow1211YesNo
18679813Auto-injectorMay 2024April 2025Allow1020YesNo
18679896Auto-injectorMay 2024July 2025Allow1331YesNo
18680073Auto-injectorMay 2024May 2025Allow1111NoNo
18678521Auto-injectorMay 2024January 2025Allow810YesNo
18678364Auto-injectorMay 2024January 2025Allow810YesNo
18679377Auto-injectorMay 2024May 2025Allow1221NoNo
18678282Auto-injectorMay 2024September 2024Allow300YesNo
18598482HEMOSTASIS VALVES AND METHODS OF USEMarch 2024July 2024Allow501YesNo
18504447Fluid Delivery DeviceNovember 2023February 2026Allow2711NoNo
18354139Syringe WarmerJuly 2023July 2025Allow2411YesNo
18220128MEDICAMENT DELIVERY DEVICEJuly 2023September 2025Allow2620NoNo
18206738SYSTEM AND METHOD FOR CLOSED-LOOP PATIENT-ADAPTIVE HEMODYNAMIC MANAGEMENTJune 2023February 2025Allow2001NoNo
18328866Method and system for providing a therapeutic agent to an implanted infusion deviceJune 2023November 2025Allow3021NoNo
18196927CONTACT SENSOR FOR MONITORING MEDICATION ADHERENCEMay 2023August 2025Abandon2710NoNo
18142518HEMOSTASIS VALVES AND METHODS OF USEMay 2023August 2023Allow300NoNo
18310746Packaging AssemblyMay 2023February 2026Allow3421YesNo
18306528MEDICAMENT DELIVERY DEVICEApril 2023April 2025Allow2310NoNo
18135636DEVICES AND METHODS FOR INSTALLATION AND REMOVAL OF A NEEDLE TIP OF A NEEDLEApril 2023April 2025Allow2410NoNo
18246631DRUG DELIVERY DEVICE CASSETTEMarch 2023November 2024Allow1931YesNo
18102325Devices and Methods for Fluid Transfer Through a Placed Peripheral Intravenous CatheterJanuary 2023June 2023Allow401NoNo
18085193MEDICAMENT DELIVERY DEVICEDecember 2022September 2024Allow2100YesNo
17989314DYNAMICALLY CONTROLLABLE PATIENT FLUID CONTROL DEVICENovember 2022March 2025Allow2810YesNo
17981154APPARATUS AND METHODS FOR INTRAVENOUS GAS ELIMINATIONNovember 2022July 2025Abandon3311NoNo
17971266EXPANDABLE MOUTH CATHETEROctober 2022February 2024Allow1620YesNo
18047729Deformable Drug Reservoir For Wearable Drug Delivery DeviceOctober 2022April 2025Allow2911NoNo
17935237AUTO-INJECTORSeptember 2022April 2025Allow3010YesNo
17888327COMPUTERIZED ORAL PRESCRIPTION ADMINISTRATION WITH REFILLABLE MEDICATION DISPENSING DEVICES AND ASSOCIATED SYSTEMS AND METHODSAugust 2022August 2024Allow2400NoNo
17819780DEVICE AND METHOD FOR SINGLE-HANDED ACCESS AND INSERTION OF AN ARTICLEAugust 2022July 2024Allow2301NoNo
17886584ROBOTIC SURGICAL INSTRUMENTSAugust 2022October 2025Allow3901NoNo
17870988DISPLAY FOR WEARABLE DRUG DELIVERY DEVICEJuly 2022June 2025Abandon3421NoNo
17865266HEMOSTASIS VALVES AND METHODS OF USEJuly 2022November 2022Allow401YesNo
17745007OCULAR IMPLANT DELIVERY DEVICE AND METHODMay 2022February 2025Allow3311YesNo
17734764SYSTEMS FOR WEARABLE INFUSION PORT AND ASSOCIATED PUMPMay 2022August 2024Allow2800NoNo
17721613COMPONENT POSITIONING OF A LINEAR SHUTTLE PUMPApril 2022August 2024Allow2800YesNo
17657119Device and Method for Single-Handed Access and Insertion of an ArticleMarch 2022May 2024Allow2601NoNo
17706380AUTO-INJECTORMarch 2022July 2025Allow3911NoNo
17705189HEMOSTASIS VALVES AND METHODS OF USEMarch 2022December 2022Allow911YesNo
17685149AMBULATORY MEDICAMENT DEVICE WITH MOTION DETECTION AND GESTURE-BASED CONTROLMarch 2022August 2022Allow601NoNo
17588666VIAL CLOSURE FOR REHYDRATING MEDICATIONJanuary 2022June 2025Allow4020YesNo
17624631MEDICAL FLUID INJECTION AND TRANSFER DEVICES AND METHODJanuary 2022August 2025Allow4411YesNo
17555834THIN-WALLED TUBES WITH COMMUNICATION PATHWAYSDecember 2021September 2025Abandon4501NoNo
17554125COAXIAL BI-DIRECTIONAL CATHETERDecember 2021June 2024Allow3000YesNo
17552407LINEAR SHUTTLE PUMP FOR DRUG DELIVERYDecember 2021November 2024Allow3501NoNo
17552337Buffering Agent CartridgeDecember 2021July 2024Allow3101YesNo
17528319Imaging MarkerNovember 2021February 2026Abandon5140NoNo
17522878RAPID DELIVERY AND/OR RECEIVING OF FLUIDSNovember 2021May 2024Allow3000YesNo
17604781Wearable InjectorOctober 2021April 2022Allow600YesNo
17504387BEND-LIMITED CATHETERSOctober 2021October 2024Abandon3601NoNo
17496432MEDICAL INSTRUMENT ELECTRICALLY ENERGIZED USING DRIVE CABLESOctober 2021November 2024Allow3811YesNo
17492007BLOOD GLUCOSE CONTROL SYSTEM WITH MEDICAMENT BOLUS RECOMMENDATIONOctober 2021December 2024Abandon3811YesNo
17489610SYSTEM AND METHODS FOR WIRELESS DRUG DELIVERY ON COMMANDSeptember 2021July 2024Allow3411YesNo
17489056Infusion Pump AssemblySeptember 2021August 2024Allow3510YesNo
17486517AMBULATORY MEDICAL DEVICE WITH MALFUNCTION ALERT PRIORITIZATIONSeptember 2021February 2024Allow2801YesNo
17465775Conduit for Transseptal Passage to the AortaSeptember 2021April 2024Allow3100YesNo
17460594FIXATION OF RESERVOIR OF DRUG DELIVERY DEVICEAugust 2021April 2024Allow3200YesNo
17446297Annealing of Discrete Sections of a Reinforcement Layer to Modulate Stiffness of a CatheterAugust 2021June 2025Abandon4540YesNo
17412729WEARABLE MICRO-DOSING DRUG DELIVERY DEVICEAugust 2021May 2024Allow3311NoNo
17408554Infusion Pump Apparatus, Method and SystemAugust 2021August 2024Allow3610NoNo
17396265SERVICING REGIME FOR A DISPOSABLE SET OF A MEDICAL FLUID THERAPY MACHINEAugust 2021November 2025Allow5221YesNo
17444421METHOD AND APPARATUS FOR INJECTING FLUIDSAugust 2021April 2024Allow3200NoNo
17443565INTERLOCKING SYSTEM AND METHOD FOR JOYSTICKS IN A CATHETER PROCEDURE SYSTEMJuly 2021May 2024Allow3410YesNo
17424729Feeding Cap, Drive Head, And Drive SystemJuly 2021July 2024Allow3501YesNo
17380997DEVICES, SYSTEMS, AND METHODS USEFUL TO ENGAGE TISSUE USING SUCTION AND TO PERFORM MEDICAL PROCEDURES DURING SUCTIONAL ENGAGEMENTJuly 2021June 2024Abandon3501NoNo
17377491COAXIAL BI-DIRECTIONAL CATHETERJuly 2021July 2024Allow3610YesNo
17417820SHELL FOR A PORTABLE ELECTROMECHANICAL APPARATUS FOR DRUG INFUSIONJune 2021November 2024Allow4120NoNo
17349209CROSSING OCCLUSIONS IN BLOOD VESSELSJune 2021October 2025Allow5260NoYes
17347994METHODS FOR IN SITU FABRICATION OF SENSOR ELECTRODES, AND MEDICAL SYSTEMS AND DEVICES EMPLOYING SUCH SENSOR ELECTRODESJune 2021September 2025Abandon5101NoNo
17329795METHOD OF TREATMENT FOR VARIOUS DISEASESMay 2021May 2024Abandon3601NoNo
17329823METHOD OF TREATMENT FOR VARIOUS DISEASESMay 2021May 2024Abandon3601NoNo
17329765METHOD OF TREATMENT FOR VARIOUS DISEASESMay 2021May 2024Abandon3601NoNo
17329842METHOD OF TREATMENT FOR VARIOUS DISEASESMay 2021June 2024Abandon3701NoNo
17330132SYSTEMS AND METHODS FOR MASS AIR FLOW CONTROL IN VACUUM BASED ASPIRATION IN SURGICAL SYSTEMMay 2021March 2024Allow3400NoNo
17246116Deformable Drug Reservoir For Wearable Drug Delivery DeviceApril 2021July 2022Allow1421YesNo
17287261StopcockApril 2021April 2025Abandon4820NoNo
17284761Stepping DoserApril 2021November 2024Abandon4410NoNo
17226318HEMOSTASIS VALVES AND METHODS OF USEApril 2021October 2023Allow3000YesNo
17222570CLOSED-LOOP CONTROL IN STEADY-STATE CONDITIONSApril 2021October 2023Allow3000NoNo
17218464APPLICATOR FOR DELIVERY OF A PRODUCT THERETHROUGHMarch 2021January 2024Allow3410NoNo
17281271SUBCUTANEOUS DELIVERY MECHANISM FOR DRUG DELIVERY DEVICEMarch 2021August 2021Allow400YesNo
17216246SELF-CONTAINED SPRING INSERTER FOR DRUG DELIVERY INFUSION SETMarch 2021August 2023Allow2900YesNo
17057632AUTOMATED SYSTEM FOR MONITORING A PATIENT'S BLOOD SUGARMarch 2021February 2024Allow3900NoNo
17197420INTEGRATED USER-DEFINED INPUT INTO A CLOSED-LOOP GLUCOSE CONTROL SYSTEMMarch 2021January 2022Abandon1110NoNo
17180429Display for Wearable Drug Delivery DeviceFebruary 2021April 2022Allow1321YesNo
17180221Sensing Fluid Flow Irregularities In An On-Body InjectorFebruary 2021May 2021Allow300YesNo
17179070AUTOMATED SUPER BOLUS GENERATIONFebruary 2021August 2023Allow3000NoNo
17160036NEEDLE-LESS INJECTOR AND METHOD OF FLUID DELIVERYJanuary 2021September 2023Allow3201NoNo
17157211FLUTE CATHETER AND METHODS OF USING THE SAMEJanuary 2021November 2024Abandon4501NoNo
17153254DEVICES, SYSTEMS AND METHODS FOR MEDICAMENT DELIVERYJanuary 2021March 2024Abandon3801NoNo
17256735Vascular Access TubeDecember 2020February 2025Abandon4921NoNo
17123369TECHNIQUES FOR IMPROVED AUTOMATIC DRUG DELIVERY PERFORMANCE USING DELIVERY TENDENCIES FROM PAST DELIVERY HISTORY AND USE PATTERNSDecember 2020July 2023Allow3101NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner VU, QUYNH-NHU HOANG.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
7
Examiner Affirmed
6
(85.7%)
Examiner Reversed
1
(14.3%)
Reversal Percentile
26.7%
Lower than average

What This Means

With a 14.3% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
48
Allowed After Appeal Filing
16
(33.3%)
Not Allowed After Appeal Filing
32
(66.7%)
Filing Benefit Percentile
55.5%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner VU, QUYNH-NHU HOANG - Prosecution Strategy Guide

Executive Summary

Examiner VU, QUYNH-NHU HOANG works in Art Unit 3783 and has examined 456 patent applications in our dataset. With an allowance rate of 73.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner VU, QUYNH-NHU HOANG's allowance rate of 73.7% places them in the 38% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by VU, QUYNH-NHU HOANG receive 1.88 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by VU, QUYNH-NHU HOANG is 35 months. This places the examiner in the 41% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +31.9% benefit to allowance rate for applications examined by VU, QUYNH-NHU HOANG. This interview benefit is in the 80% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 26.0% of applications are subsequently allowed. This success rate is in the 42% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.7% of cases where such amendments are filed. This entry rate is in the 22% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 126.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 84% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 80.6% of appeals filed. This is in the 74% percentile among all examiners. Of these withdrawals, 62.1% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 51.9% are granted (fully or in part). This grant rate is in the 51% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 3.5% of allowed cases (in the 81% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.